ITPR3 and cancer: Conversely, BCL2, another oncogene enriched in MAMs, directly interacts with IP3R, preventing Ca2+ transport from the ER to the mitochondria and interfering with the release of cytochrome c from the mitochondria, thus playing a role in resisting apoptosis in cancer [230].